חוב לטווח קצר להון עצמי Context Therapeutics (CNTX)

The price visualization on GURU.Markets for Context Therapeutics (CNTX), where the indicator stands at 0.01, demonstrates the activity of the biotech company developing drugs against hormonal tumors to combat resistance in uterine and breast cancers. The business relies on patent protection for proprietary molecules, which guarantees long-term exclusive revenue. Asset value growth is driven exclusively by successes during closed clinical trials of new treatment methods.

This indicator measures the proportion of liabilities maturing within one year relative to equity, reflecting the issuer's current financial stability and liquidity risk. Analyzing the short-term debt-to-equity ratio is critically important for Context Therapeutics (CNTX), as a low debt load provides the necessary margin of safety to scale successful oncology molecules across the global market.